Ditchcarbon
  • Customers
  1. Organizations
  2. Cmic Holdings Co
Public Profile
Research Services
JP
updated a month ago

Cmic Holdings Co

Company website

Cmic Holdings Co., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Japan (JP) and operates extensively across Asia and beyond. Founded in 2006, the company has established itself as a leader in contract research and manufacturing services, catering to a diverse clientele in the life sciences sector. Cmic Holdings is renowned for its comprehensive range of services, including drug development, clinical trial management, and regulatory affairs. What sets them apart is their commitment to innovation and quality, ensuring that clients receive tailored solutions that meet stringent industry standards. With a strong market position, Cmic Holdings has achieved significant milestones, including strategic partnerships and expansions that enhance its service offerings.

DitchCarbon Score

How does Cmic Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

34

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Cmic Holdings Co's score of 34 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Cmic Holdings Co's reported carbon emissions

In 2024, Cmic Holdings Co., based in Japan, reported total carbon emissions of approximately 8,000,000 kg CO2e, comprising 1,000,000 kg CO2e from Scope 1 and 7,000,000 kg CO2e from Scope 2. This marks a significant reduction from 2022, when the company emitted about 44,000,000 kg CO2e (14,000,000 kg CO2e from Scope 1 and 29,000,000 kg CO2e from Scope 2). The company has committed to near-term climate targets, although it has not set a net-zero target. Cmic Holdings is actively engaged in reducing its carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. The emissions data is self-reported and does not include Scope 3 emissions, which are often a significant part of a company's overall carbon footprint. Cmic Holdings' emissions data is not cascaded from a parent company, indicating that the figures are independently reported. The company continues to focus on sustainability initiatives as part of its corporate responsibility strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
-
-
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
Scope 2
-
-
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cmic Holdings Co's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cmic Holdings Co is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cmic Holdings Co is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Quintiles Transnational Corp.

US
•
Research and development services (73)
Updated about 1 month ago

Inizio

IE
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Illumina

US
•
Research and development services (73)
Updated 2 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250829.2
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy